Skip to main content
Clinical Trials/KCT0002038
KCT0002038Recruiting未知

Response-based treatment of high-risk neuroblastoma

Samsung Medical Center0 sites54 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Enrollment
54

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional Study

Eligibility Criteria

Ages
o Limit to o Limit (—)
Sex
All

Inclusion Criteria

  • 1. Patients with newly diagnosed high risk neuroblastoma
  • 2. Patients with measurable or evaluable disease
  • 3. Patients with informed consent

Exclusion Criteria

  • 1. Patients with progressive disease or relapse
  • 2. Patients who underwent high dose chemotherapy before
  • 3. Patients with organ dysfunction as follows (creatinine elevation > 3 x upper limit of normal, Total bilirubin > 3 x upper limit of normal, aspartate transaminase/alanine transaminase > 5 x upper limit of normal), ejection fraction <40%)
  • 4. Pregnant or nursing women

Investigators

Similar Trials